These effects, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the concept of targeting ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-connected Problems. By ticking this box and submitting https://toddf627vyw2.wikimillions.com/user